Kentucky HB735 regulates pharmacists by implementing FDA standards for electronic track and trace systems for prescription drugs.
Kentucky HB735 mandates that the Board of Pharmacy must not require the use of an electronic track and trace system for prescription drugs until the FDA develops and implements relevant standards. Upon FDA implementation, the board must consult with manufacturers, wholesale distributors, and pharmacies, and publish a report on implementation issues. The FDA standards will supersede existing state requirements for prescription drugs covered by these standards.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.